Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Geng YJ"" wg kryterium: Autor


Tytuł:
Pathogenesis and management of myocardial injury in coronavirus disease 2019.
Autorzy:
Wei ZY; Center for Coronary Heart Disease, Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases of China, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Geng YJ; Center for Cardiovascular Biology and Atherosclerosis Research, Department of Internal Medicine, McGovern School of Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.
Huang J; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Qian HY; Center for Coronary Heart Disease, Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases of China, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2020 Nov; Vol. 22 (11), pp. 1994-2006. Date of Electronic Publication: 2020 Aug 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
COVID-19/*complications
Cardiovascular Diseases/*virology
COVID-19/epidemiology ; Cardiovascular Diseases/epidemiology ; Cardiovascular Diseases/therapy ; Humans ; Pandemics ; Risk Factors ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
Oral delivery of xenon for cardiovascular protection.
Autorzy:
Yin X; Division of Cardiovascular Medicine, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, 77030, USA.
Moody MR; Division of Cardiovascular Medicine, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, 77030, USA.
Hebert V; Department of Comparative Biomedical Science, School of Veterinary Medicine, Louisiana State University Health Science Center, Shreveport, Louisiana, 71103, USA.
Klegerman ME; Division of Cardiovascular Medicine, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, 77030, USA.
Geng YJ; Division of Cardiovascular Medicine, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, 77030, USA.
Dugas TR; Department of Comparative Biomedical Science, School of Veterinary Medicine, Louisiana State University Health Science Center, Shreveport, Louisiana, 71103, USA.
McPherson DD; Division of Cardiovascular Medicine, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, 77030, USA.
Kim H; Division of Cardiovascular Medicine, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, 77030, USA. .; Department of Biomechatronic Engineering, Sungkyunkwan University, Suwon, Gyeonggi, 16419, Korea. .
Huang SL; Division of Cardiovascular Medicine, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, 77030, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Oct 01; Vol. 9 (1), pp. 14035. Date of Electronic Publication: 2019 Oct 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiotonic Agents/*administration & dosage
Cardiovascular System/*drug effects
Xenon/*administration & dosage
2-Hydroxypropyl-beta-cyclodextrin/administration & dosage ; Administration, Oral ; Animals ; Apolipoproteins E/genetics ; Blood Pressure/drug effects ; Heart/drug effects ; Hypertension/drug therapy ; Hypertrophy, Left Ventricular/drug therapy ; Male ; Mice, Inbred C57BL ; Mice, Knockout ; Solubility ; Solutions/administration & dosage
Czasopismo naukowe
Tytuł:
MiRNA-Sequence Indicates That Mesenchymal Stem Cells and Exosomes Have Similar Mechanism to Enhance Cardiac Repair.
Autorzy:
Shao L; Department of Cardiovascular Surgery, The First Affiliated Hospital and The Institute for Cardiovascular Science, Soochow University, Suzhou, Jiangsu 215123, China.
Zhang Y; Department of Cardiovascular Surgery, The First Affiliated Hospital and The Institute for Cardiovascular Science, Soochow University, Suzhou, Jiangsu 215123, China.
Lan B; Department of Cardiovascular Surgery, The First Affiliated Hospital and The Institute for Cardiovascular Science, Soochow University, Suzhou, Jiangsu 215123, China.
Wang J; Department of Cardiovascular Surgery, The First Affiliated Hospital and The Institute for Cardiovascular Science, Soochow University, Suzhou, Jiangsu 215123, China.
Zhang Z; Department of Cardiovascular Surgery, The First Affiliated Hospital and The Institute for Cardiovascular Science, Soochow University, Suzhou, Jiangsu 215123, China.
Zhang L; Department of Cardiovascular Surgery, The First Affiliated Hospital and The Institute for Cardiovascular Science, Soochow University, Suzhou, Jiangsu 215123, China.
Xiao P; Department of Cardiovascular Surgery, The First Affiliated Hospital and The Institute for Cardiovascular Science, Soochow University, Suzhou, Jiangsu 215123, China.
Meng Q; Department of Cardiovascular Surgery, The First Affiliated Hospital and The Institute for Cardiovascular Science, Soochow University, Suzhou, Jiangsu 215123, China.
Geng YJ; Department of Internal Medicine, University of Texas, Houston, TX 77583, USA.
Yu XY; Guangzhou Medical University, Guangzhou, Guangdong 510080, China.
Li Y; Department of Cardiovascular Surgery, The First Affiliated Hospital and The Institute for Cardiovascular Science, Soochow University, Suzhou, Jiangsu 215123, China.
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2017; Vol. 2017, pp. 4150705. Date of Electronic Publication: 2017 Jan 22.
Typ publikacji:
Journal Article
MeSH Terms:
Mesenchymal Stem Cell Transplantation*
Mesenchymal Stem Cells/*metabolism
MicroRNAs/*biosynthesis
Myocardial Infarction/*therapy
Regeneration/*genetics
Animals ; Apoptosis/genetics ; Cell Differentiation/genetics ; Cell Proliferation/genetics ; Exosomes/genetics ; Exosomes/metabolism ; Gene Expression Regulation ; Gene Expression Regulation, Developmental/genetics ; Humans ; MicroRNAs/genetics ; Myocardial Infarction/genetics ; Myocardial Infarction/pathology ; Myocardium/metabolism ; Myocardium/pathology ; Myocytes, Cardiac/metabolism ; Neovascularization, Physiologic/genetics ; Paracrine Communication/genetics ; Rats
Czasopismo naukowe
Tytuł:
High glucose-induced hyperosmolarity contributes to COX-2 expression and angiogenesis: implications for diabetic retinopathy.
Autorzy:
Madonna R; Laboratory of Experimental Cardiology, Center of Excellence on Aging, Institute of Cardiology, 'G. d'Annunzio' University, C/o Ospedale SS. Annunziata, Via dei Vestini, 31, 66013, Chieti, Italy. .; The University of Texas Health Science Center at Houston and the Texas Heart Institute, Houston, TX, USA. .
Giovannelli G; Department of Neurosciences and Imaging, 'G. d'Annunzio' University, Chieti, Italy. .
Confalone P; Laboratory of Experimental Cardiology, Center of Excellence on Aging, Institute of Cardiology, 'G. d'Annunzio' University, C/o Ospedale SS. Annunziata, Via dei Vestini, 31, 66013, Chieti, Italy. .
Renna FV; Laboratory of Experimental Cardiology, Center of Excellence on Aging, Institute of Cardiology, 'G. d'Annunzio' University, C/o Ospedale SS. Annunziata, Via dei Vestini, 31, 66013, Chieti, Italy. .
Geng YJ; The University of Texas Health Science Center at Houston and the Texas Heart Institute, Houston, TX, USA. yong-jian.geng@uth.tmc.edu.
De Caterina R; Laboratory of Experimental Cardiology, Center of Excellence on Aging, Institute of Cardiology, 'G. d'Annunzio' University, C/o Ospedale SS. Annunziata, Via dei Vestini, 31, 66013, Chieti, Italy. .
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2016 Jan 29; Vol. 15, pp. 18. Date of Electronic Publication: 2016 Jan 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neovascularization, Pathologic*
Cyclooxygenase 2/*metabolism
Diabetic Retinopathy/*enzymology
Endothelial Cells/*enzymology
Glucose/*metabolism
Animals ; Aquaporin 1/genetics ; Aquaporin 1/metabolism ; Cell Movement ; Cells, Cultured ; Diabetes Mellitus, Type 1 ; Diabetic Retinopathy/genetics ; Diabetic Retinopathy/pathology ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Endothelial Cells/drug effects ; Endothelial Cells/pathology ; Glucose/toxicity ; Humans ; Male ; Mannitol/toxicity ; Mice, Inbred C57BL ; Osmolar Concentration ; RNA Interference ; Signal Transduction ; Transcription Factors/genetics ; Transcription Factors/metabolism ; Transfection
Czasopismo naukowe
Tytuł:
Atorvastatin enhance efficacy of mesenchymal stem cells treatment for swine myocardial infarction via activation of nitric oxide synthase.
Autorzy:
Song L; Coronary Heart Disease Center, Department of Cardiology, Fuwai Hospital and Cardiovascular Institute, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yang YJ
Dong QT
Qian HY
Gao RL
Qiao SB
Shen R
He ZX
Lu MJ
Zhao SH
Geng YJ
Gersh BJ
Pokaż więcej
Źródło:
PloS one [PLoS One] 2013 May 31; Vol. 8 (5), pp. e65702. Date of Electronic Publication: 2013 May 31 (Print Publication: 2013).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Mesenchymal Stem Cell Transplantation*
Heptanoic Acids/*pharmacology
Myocardial Infarction/*metabolism
Myocardial Infarction/*therapy
Nitric Oxide Synthase/*metabolism
Pyrroles/*pharmacology
Animals ; Apoptosis/drug effects ; Atorvastatin ; C-Reactive Protein/metabolism ; Disease Models, Animal ; Enzyme Activation/drug effects ; Fibrosis ; Heptanoic Acids/administration & dosage ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology ; Inflammation/metabolism ; Inflammation/pathology ; Myocardial Infarction/diagnosis ; Myocardial Infarction/mortality ; Myocardial Infarction/physiopathology ; Myocardium/metabolism ; Myocardium/pathology ; Nitric Oxide/metabolism ; Nitric Oxide Synthase Type III/metabolism ; Pyrroles/administration & dosage ; Swine ; Tomography, Emission-Computed, Single-Photon ; Ventricular Function, Left/drug effects
Czasopismo naukowe
Tytuł:
Neuroprotective effects of ischemic preconditioning and postconditioning on global brain ischemia in rats through the same effect on inhibition of apoptosis.
Autorzy:
Ding ZM; Neuroscience Center, Wuxi No. 2 Hospital, Nanjing Medical University, Wuxi 214002, China.
Wu B; Department of Neurosurgery, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Zhang WQ; Department of Neurosurgery, Yuyao People's Hospital, Yuyao 315472, China.
Lu XJ; Neuroscience Center, Wuxi No. 2 Hospital, Nanjing Medical University, Wuxi 214002, China.
Lin YC; Neuroscience Center, Wuxi No. 2 Hospital, Nanjing Medical University, Wuxi 214002, China.
Geng YJ; University of Texas Medical School at Houston, Houston, TX 77030, USA.
Miao YF; Neuroscience Center, Wuxi No. 2 Hospital, Nanjing Medical University, Wuxi 214002, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2012; Vol. 13 (5), pp. 6089-6101. Date of Electronic Publication: 2012 May 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Brain Ischemia/*pathology
CA1 Region, Hippocampal/*blood supply
Ischemic Postconditioning/*methods
Ischemic Preconditioning/*methods
Neurons/*cytology
Animals ; Apoptosis ; Brain Ischemia/genetics ; Brain Ischemia/metabolism ; CA1 Region, Hippocampal/pathology ; Caspases/metabolism ; Cells, Cultured ; DNA Fragmentation ; Disease Models, Animal ; Gene Expression Regulation ; Neurons/pathology ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Rats ; bcl-2-Associated X Protein/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies